Molecular and Cellular Changes in the Cancer Cell

Kevin Pruitt received a BS degree in Chemical Engineering from University of Texas at Austin followed by post-baccalaureate research training in the biological sciences at the Los Alamos National Laboratory. He then moved on to the University of North Carolina at Chapel Hill, for doctoral studies in Pharmacology in 2001 followed by postdoctoral training at the Johns Hopkins School of Medicine. Dr. Pruitt has received numerous research awards during his career, serves as a member of National Cancer Institute study sections, and directs a vibrant research program where graduate students and postdoctoral trainees contribute to the discovery process in basic and translational cancer research. He joined the Physiology Department as an assistant professor at LSUHSC in Shreveport, Louisiana in 2006. He was then recruited to the Department of Immunology & Molecular Microbiology at TTUHSC in Lubbock, Texas in 2014 where his group continues to focus on identifying novel factors that contribute to colon and breast tumor progression.

• 1. Molecular and Cellular Changes During Cancer Progression Resulting from Genetic and Epigenetic AlterationsK. Pruitt2. Wnt/β Catenin-mediated Signaling Commonly Altered in Colorectal CancerJ. Deitrick and W.M. Pruitt3. Interplay between Inflammation and Epigenetic Changes in CancerA.R. Maiuri and H.M. O’Hagan4. Viral CarcinogenesisA.J. Smith and L.A. Smith5. The Interaction between Human Papillomaviruses and the Stromal MicroenvironmentB. Woodby, M. Scott and J. Bodily6. Molecular Pathogenesis of Pancreatic CancerT.J. Grant, K. Hua and A. Singh7. Current and Emerging Targeting Strategies for Treatment of Pancreatic CancerA.T. Baines, P.M. Martin and C.J. Rorie8. Molecular Changes Associated with Tumor Initiation and Progression of Soft Tissue Sarcomas; Targeting the Genome and EpigenomeP.W. Halcrow, M. Dancer, M. Panteah, C. Walden and J.E. Ohm9. Molecular Changes During Acute Myeloid Leukemia (AML) Evolution and Identification of Novel Treatment Strategies Through Molecular StratificationE. Karjalainen and G.A. Repasky10. Myeloproliferative Neoplasms: Molecular Drivers and TherapeuticsG.W. Reuther11. Dysregulation of Aromatase in Breast, Endometrial, and Ovarian Cancers: An Overview of Therapeutic StrategiesP.R. Manna, D. Molehin and A.U. Ahmed 12. Molecular Changes During Breast Cancer and Mechanisms of Endocrine Therapy ResistanceS. Radhi13. Molecular and Cellular Changes in Breast Cancer and New Roles of lncRNAs in Breast Cancer Initiation and ProgressionM. Kumar, R.S. DeVaux and J.I. Herschkowitz